Cite

HARVARD Citation

    Marshall, A. et al. (n.d.). PO-36 Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomisation of the SELECT-D trial. Thrombosis research. pp. S36-. [Online]. 
  
Back to record